Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-22

Clinical Trial Update: Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating whether HPV vaccination reduces the burden of disease in patients with actinic keratosis. The study status is ACTIVE_…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HPV vaccine

Snippet

Sponsor: Merete Haedersdal | Conditions: Actinic Keratoses, Basal Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING